GlobeNewswire Inc.··Researchandmarkets.ComVulvar Cancer Market Poised for Growth Through 2035 as Pharma Giants Push Innovation
Global vulvar cancer market expected to expand through 2035, driven by aging populations and HPV prevalence. Merck, Bristol Myers Squibb, and AstraZeneca lead innovation in immunotherapies despite reimbursement headwinds.
BMYCELGrMRKAZNemerging marketsearly detection